Fit for purpose? A cross-sectional study to evaluate the acceptability and usability of HeadUp, a novel neck support collar for neurological neck weakness.

HeadUp collar Neck orthoses amyotrophic lateral sclerosis cervical orthoses motor neuron disease

Journal

Amyotrophic lateral sclerosis & frontotemporal degeneration
ISSN: 2167-9223
Titre abrégé: Amyotroph Lateral Scler Frontotemporal Degener
Pays: England
ID NLM: 101587185

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 11 9 2020
medline: 1 9 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

The HeadUp collar (previously known as the Sheffield Support Snood) provides support for neck weakness caused by amyotrophic lateral sclerosis (ALS) and has shown to be superior to alternative options in a small cohort of patients from one single center. Here we report the assessment of the HeadUp collar in a larger cohort of patients, exploring the use in other neurological conditions and expanding to other centers across the UK and Ireland. An interventional cross-sectional study design was implemented to investigate the usability and acceptability of the HeadUp collar. A total of 139 patients were recruited for the study, 117 patients had a diagnosis of ALS and 22 patients presented with neck weakness due to other neurological conditions. Participants were assessed at baseline, fitted a HeadUp collar and followed-up one month later. The performance of the HeadUp collar was rated favorably compared to previously worn collars in terms of the ability to eat, drink and swallow. Findings suggest that the collar also permitted a more acceptable range of head movements whilst maintaining a good level of support. We conclude that the HeadUp collar is a suitable option for patients with neck weakness due to ALS and other neurological conditions.

Identifiants

pubmed: 32909466
doi: 10.1080/21678421.2020.1813308
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-45

Auteurs

Lise Sproson (L)

NIHR Devices for Dignity MedTech Co-operative, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Vitaveska Lanfranchi (V)

NIHR Devices for Dignity MedTech Co-operative, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Department of Medical Physics and Clinical Engineering, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Department of Computer Science, The University of Sheffield, Sheffield, UK.

Alexis Collins (A)

Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.

Suresh K Chhetri (SK)

Department of Neurology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.

Niamh Daly (N)

Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland.

Michelle Ennis (M)

The Walton Centre NHS Foundation Trust, University of Liverpool, Liverpool, UK.

Lucie Glennon (L)

Department of Medicine, The University of Sheffield, Sheffield, UK.

George Gorrie (G)

NHS Greater Glasgow and Clyde, Glasgow, UK.

Emily Jay (E)

King's College Hospital, King's College NHS Foundation Trust, King's College London, London, UK.

Rachael Marsden (R)

Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Avril D McCarthy (AD)

NIHR Devices for Dignity MedTech Co-operative, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Department of Medical Physics and Clinical Engineering, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Liz Pryde (L)

NIHR Devices for Dignity MedTech Co-operative, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Rhys Roberts (R)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Anna Rutherford (A)

Department of Neurology, Salford Royal Hospital Foundation Trust, Salford, UK.

Jessica Ryan (J)

King's College Hospital, King's College NHS Foundation Trust, King's College London, London, UK.

Gill Stot (G)

Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.

Wendy B Tindale (WB)

NIHR Devices for Dignity MedTech Co-operative, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Department of Medical Physics and Clinical Engineering, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Pamela J Shaw (PJ)

Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.

Christopher J McDermott (CJ)

NIHR Devices for Dignity MedTech Co-operative, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH